Background: Pseudomonas aeruginosa is a major cause of hospital-acquired infection due to its high antibiotic resistance and biofilm formation ability. P. aeruginosa produces elastase lasB during biofilm formation, which can influence properties of biofilm. This study was carried out to evaluate the antibiotic resistance and distribution of the lasB gene among biofilm-producing P. aeruginosa strains isolated from burn patients. Methods: A total of 128 clinical samples were collected from burn patients. The P. aeruginosa isolates were identified using standard bacteriological procedures. Antibiotic susceptibility test was performed by the disk diffusion method. Biofilm formation was measured by microtiter plate assay. The presence of lasB gene was detected by PCR. Results: A total of 75 samples were positive for P. aeruginosa. A high rate of resistance was seen against ceftriaxone, cefotaxime, and piperacillin/tazobactam. Biofilm formation was seen in 57.3% of the isolates and the prevalence of the lasB gene was 85.3%. Biofilm formation in isolates without lasB was lower and these isolates were more sensitive to imipenem and piperacillin/tazobactam. Conclusions: In the present study, we did not find a statistically significant relationship among elastase gene (lasB) presence, antibiotic resistance, and biofilm formation in P. aeruginosa strains isolated from burn patients. (Clin. Lab. 2018;64:xx-xx.
INTRODUCTION
P. aeruginosa is an opportunistic pathogen, non-fermentative, aerobic, and gram-negative rod-shaped bacteria, commonly found in diverse environments, such as water, soil, and plants, that can infect different organisms, including plants, animals, and humans [1, 2] . Its ecological success is due to its remarkable degree of genomic flexibility and phenotypic adaptation [3] . This bacterium is the most frequently isolated gram-negative organism in the bloodstream and wound infections as well as in patients with pneumonia, intra-abdominal and urogenital sepsis. It is a serious problem, infecting immune compromised patients with cystic fibrosis, severe burns, cancer, and AIDS, among others [4] . This opportunistic pathogen can be isolated from 50% to 60% of the hospitalized patients (especially found in burns and scabs), as opposed to 1.2 -6% in the cases of healthy individuals. One of the most common causes of healthcare-associated infections, P. aeruginosa represented 8 -11% of the reported nosocomial infections in Europe and the United States between 2001 and 2010 [5] . Burn injury, one of the significant public health problems worldwide, is at high risk for nosocomial infections. Although present techniques of burn wound care have significantly reduced the incidence of infections, severely burned patients may still develop life-threatening infections. P. aeruginosa is a major microorganism causing severe, acute, and chronic nosocomial infections, particularly in burn patients [6] . The condition of patients infected with this bacterium is particularly problematic since the organism is intrinsically resistant to many drug classes and can become resistant to all effective antimicrobial drugs. The widespread use of antibiotics is believed to be the main reason for the increase in drug resistance among P. aeruginosa strains. In recent years, P. aeruginosa has caused severe infections in patients with burn injuries and showed increased resistance to various antimicrobial agents [7, 8] . The pathogenesis of chronic P. aeruginosa infections is mainly due to the capacity of P. aeruginosa to form biofilms, which are structured communities of bacteria encased in a self-produced polymeric matrix, during the infection process [9] . Biofilm formation demonstrates a protective mode of growth which allows the bacterium to survive in different environments. The persistence of long-lasting infections caused by biofilm-forming P. aeruginosa isolates has created serious problems in burn hospitals as such infections are difficult to treat, even if the individual shows normal immune response [10] . Extracellular polymeric substances (EPS) consist of polysaccharides, nucleic acids, lipids, and proteins. The EPS matrix makes up the majority (50 -90%) of the volume of the biofilm and imparts both a physical and chemical robustness to the community by resisting mechanical forces and decreasing the penetration of toxic chemicals [11] . Little is known about the extracellular proteins in biofilms, but some of them can be expected to be extracellular enzymes, and some contribute to the virulence or are thought to play a role in the nutrition of the bacterium. P. aeruginosa produces extracellular enzymes during biofilm growth such as elastase lasB [12] . Elastase is a zinc metalloprotease, encoded by lasB gene that is involved in host colonization and tissue damage. Previous studies have suggested that lasB is an important virulence factor for bacterial survival from the host immune system through degradation of elastin, collagen, and immune components. Previous studies have shown a high prevalence of the lasB gene in P. aeruginosa, irrespective of the isolation origin [13, 14] . The findings indicate that directly or indirectly, lasB can influence the formation and architecture of P. aeruginosa biofilms [12] . Since the biofilm mode of existence is an essential stage in the life cycle of P. aeruginosa, the objective of the present study was to evaluate the antibiotic resistance pattern and distribution of the lasB gene among biofilmproducing P. aeruginosa isolates obtained from burn patients hospitalized in Taleghani hospital in Ahvaz.
MATERIALS AND METHODS
Samples and identification of P. aeruginosa A total of 128 human clinical samples, including burn wound, blood, and urine were collected from hospitalized burn patients who were referred to Taleghani burn Hospital, Ahvaz, Iran. All samples were routinely cultured on blood agar, eosin methylene blue agar (EMB), and Pseudomonas Cetrimide Agar (PCA) media. Plates were incubated for 18 -24 hours and observed for suspected colonies of P. aeruginosa, which were identified by colony pigmentation, grape-like odor, and biochemical tests, including gram-stain, positive oxidase reaction, sugar fermentation in Triple Sugar Iron agar (TSI), beta-hemolysis on blood agar, and growth at 42°C [8, [15] [16] [17] . Some of the pure colonies on PCA were transferred to skim milk and were stored in refrigerator at -20°C.
Antibiotic susceptibility test
Antimicrobial susceptibility testing of all the P. aeruginosa isolates was performed on the Mueller-Hinton agar by the Kirby-Bauer disk diffusion method recommended by Clinical and Laboratory Standards Institute (CLSI). The antimicrobial agents used in this test were as follows: Amikacin (30 μg), ceftazidime (30 μg), imipenem (10 μg), ciprofloxacin (5 μg), ceftriaxone (30 μg), azteronam (30 μg), azithromycin (15 μg), ticarcillin/clavulanic acid (75/10 μg), piperacillin/tazobactam (100/10 μg), meropenem (10 μg), cefotaxime (30 μg), colistin (10 μg), and colistin sulfate (10 μg). P. aeruginosa ATCC 27853 was used as the control organism. The results were interpreted as susceptible, intermediately susceptible, and resistant by measuring the diameter of the inhibition zone, according to the criteria designated by CLSI [18] .
DNA extraction and PCR confirmation
The DNA from P. aeruginosa isolates was extracted by a DNA extraction kit (Cinna Pure-DNA, CinnaGen, Iran) in accordance with the manufacturer's instructions [19] . The lasB gene was amplified by PCR using a specific set of primers (Metabion, Germany) F: CCAGCC CGCTGACCCACAAGCTGTA and R: CATTCCTTC CTGGAGTGCYRGCCG. PCR amplification was carried out in a 50 μL reaction mixture which contained 16 μL master mix including PCR buffer, MgCl 2 , dNTPs, Taq DNA polymerase (CinnaGen, Iran), 0.5 μL of each forward and reverse primer, and 4 μL of DNA template. About 29 μL ultra-pure water was then added to make up a final volume to 50 μL. The PCR test was carried out as follows: Five minutes initial denaturation at 95°C (one cycle), 30 cycles of denaturation at 94°C for one minute, annealing at 63°C for one minute, extension at 72°C for one minute and final extension at 72°C for seven minutes. PCR products were loaded onto a 1.5% agarose gel and visualized under UV light after staining with 1% ethidium bromide.
Biofilm formation
The P. aeruginosa isolates were analyzed for their ability to produce biofilm using a microtiter-plate assay [20] . In this method, the P. aeruginosa isolates were inoculated in 3 -5 mL tryptic soy broth (TSB) and incubated for 24 hours at 37°C. After incubation, the cultures were diluted 1:100 in TSB medium. Sterile flatbottomed 96-well polystyrene microtiter plates were inoculated with 100 μL of the bacterial suspension and incubated for 48 hours at 37°C. After incubation, the wells were washed thoroughly with PBS. Subsequently, the wells were stained with 125 μL of 0.1% crystal violet solution in water for about 10 minutes. After staining, the stain was removed and the plate was washed with distilled water and left to air dry. Then, 200 μL of 95% ethanol was added to each stained well and plates were incubated for 10 to 15 minutes at room temperature. Contents of each well were mixed by pipetting, and then 125 μL of the crystal violet/ethanol solution was transferred from each well to a separate well of an optically clear flat-bottom 96-well plate. As a control measure, uninoculated medium was used. Optical densities (OD) of each of these 125 μL samples were measured at 630 nm using a spectrophotometer. Experiments were performed in duplicate and the results averaged. The cutoff OD (ODC) for the microtiter plate test was defined as three standard deviations above the mean OD of the negative control. Isolates were classified as follows [21] : OD ≤ ODC = non-adherent, ODC < OD ≤ (2 x ODC) = weakly adherent; (2 x ODC) < OD ≤ (4 x ODC) = moderately adherent, and (4 x ODC) < OD = strongly adherent.
Statistical analysis
The data collected was analyzed using descriptive statistics (frequency and frequency percent, average), Chisquare statistical test and Fisher's exact test on IBM SPSS Statistics for Windows, version 19. Confidence interval for statistical tests was considered to be significant at 0.95.
RESULTS
Descriptive information about samples analyzed Age and gender in burn patients studied All the human clinical samples were examined using the culture and PCR techniques. Out of the 128 clinical samples, 75 (58.6%) including 15 (60%) male and 60 (80%) female were positive for P. aeruginosa. The isolates were most commonly found in burn wounds 69% (n = 52) and thereafter blood 26% (n = 19) and urine 5% (n = 4). The mean age of patients was 19.1 ± 32.9 years old and the age range of the patients was 3 days to 90 years. The mean age in men and women was 24.4 ± 36.4 and 17.7 ± 32.3, respectively.
External causes and extent of burns in burn patients studied External causes and extent of burn in patients were investigated. The main causes of burn injuries happened due to contact with fire/flames (n = 63), food and hot liquids (n = 11), and electricity (n = 1). The highest frequency of 26.7% (n = 20) was related to 80 -89% burns of the total body surface area (TBSA) ( Table 1) .
Antibiogram results of 75 strains
The antibiotic susceptibility rates (%) of the P. aeruginosa isolates are shown in Table 2 . Bacterial strains showed the highest rate of resistance to ceftriaxone (94.6%) followed by cefotaxime (90.6%) and piperacillin/tazobactam (88%), and the highest sensitivity was seen in colistin (68%), azithromycin (64%), and colistin sulfate (54.6%).
Biofilms formation in P. aeruginosa strains Of the 75 isolates, 43 (57.3%) were biofilm producers and 32 (42.7%) were non-biofilm producers. Results of PCR showed that out of 75 isolates, 64 (85.3%) had the elastase gene and 11 (14.7%) cases were without the elastase gene. The difference in P. aeruginosa with and without elastase gene is shown in Table 4 . As Table 3 shows, biofilm formation in strains lacking the elastase gene was lower (63.6 to 33.3), although this difference was not statistically significant (p = 0.101). In this study, the presence of the esterase gene was also examined. Two strains, in addition to the elastase gene, were also without the esterase gene. The results of the PCR reaction for detection of lasB gene are shown in Figure  1 .
Comparison of the antibiogram results of P. aeruginosa isolates with and without elastase gene
The comparison of antibiogram results of P. aeruginosa isolates with and without elastase gene did not show a statistically significant difference, except in the case of piperacillin/tazobactam and imipenem antibiotics. P. aeruginosa isolates without elastase gene compared with isolates with elastase gene were more sensitive to piperacillin/tazobactam and imipenem. The comparison of the two groups of strains, with and without elastase gene, is shown in Table 4 .
Comparing the outcome of treatment in strains with and without the gene elastase
The average length of stay (LOS) in patients was 13.8 ± 27.3 days. Minimum stay of patients was four days Table 2 . Antibiotic susceptibility patterns of P. aeruginosa isolates. and maximum 67 days. The rate of mortality in burn patients in this study was 69.3% (n = 52). About 28% (n = 21) of patients who left the hospital were personally satisfied. Only two patients were discharged with partial remission. Comparing the outcomes of the treatment in strains with and without elastase gene did not show any statistical significance (p = 0.076). But the mortality rate for patients hospitalized in Taleghani Hospital in 2015 was 7.9% while this rate in the patients in this study was 69.3%. Also, among the studied patients, 57 had over 50% burns of the body surface. Mortality rate in these patients was 82.5% but the mortality rate in patients with over 50% burns hospitalized in Taleghani Hospital in 2015, was 53.8%.
Result of antibiogram
Comparison of the two rates shows a higher mortality rate in the examined samples.
DISCUSSION
P. aeruginosa is an important cause of hospital-acquired infection, especially in patients admitted to critical care units such as burn care units [22] . This bacterium is characterized by its intrinsic ability to resist a wide variety of antimicrobials, and it also has remarkable potential to become resistant to important antipseudomonal agents [23, 24] . Hence, the treatment of severe infections caused by P. aeruginosa is difficult with the most common antibiotics. Emergence of multidrug resistant P. aeruginosa has been increasingly reported worldwide in healthcare centers due to inadequate or excessive use of antibiotics in medical methods [25] . Infections caused by multidrug resistant isolates lead to increase in treatment costs, hospitalization period, as well as especially morbidity and mortality rates [23] . We carried out this study to determine the antibiotics resistance pattern, the presence of lasB gene, and biofilm formation in P. aeruginosa isolates from burn patients of Taleghani Hospital in Ahvaz, Iran. The findings of this study showed that there was a high frequency of resistance against most of the tested antibiotics, except for colistin and azithromycin. In a study on burn patients at a care center in India by Bhatt et al., the percentage of resistance to tested antibiotics was as follows: Amikacin (73.2%), ceftazidime (76.79%), ciprofloxacin (71.4%), and imipenem (61%) [26] , which is in agreement with our study. In another study by Hassuna et al. in Egypt, no resistance was found to imipenem for P. aeruginosa isolated from burn patients [28] . This is inconsistent with our study. In our study, high resistance to imipenem (57.4%) was observed. In a study performed by Fazeli et al., the frequency of resistance to antibiotics was shown as follow: ceftazidime 57%, amikacin 97%, ciprofloxacin 98.7% and imipenem 98.7% [23] . They also noted that all of their isolates (100%) were susceptible to colistin, similar to Memar et al.'s study. Colistin was represented as a therapeutic agent [23, 28] . Also, in our study, maximum sensitivity was observed in the case of colistin (68%). As it is shown, the results of these two mentioned studies are in accordance with our results. In another study carried out by Tiwari et al., the resistance rate to azteronam, ciprofloxacin, ticarcillin/clavulanic acid, amikacin, imipenem, meropenem, and piperacillin/ tazobactam was 31, 43, 49, 41, 23, 44 , and 26%, respectively [29] . This is contradictory to our results. Our study showed a higher percentage of resistance to antibiotics tested.
P. aeruginosa is capable of causing chronic infections mostly due to its potential to form biofilms [30] . The bacterial population in biofilms exhibit increased resistance to antibiotics and other adversary agents. Biofilms are reported to be 100 -1,000 times less sensitive to antibiotics than their plankton counterparts. Hence, infections caused by biofilm-forming P. aeruginosa are almost impossible to eradicate [31, 32] . According to the National Institutes of Health and the Center for Disease and Prevention, it is estimated that 65 to 80% of human infectious are caused by biofilms [33] . In a study by Emami et al., 70% of the P. aeruginosa isolates produced biofilm [10] . Heydari et al. showed that 43.5% of the P. aeruginosa burn isolates formed a biofilm [30] . In another study by Ramakrishnan et al., 44% of the P. aeruginosa burn isolates were biofilm producers [34] . These reports are in correlation with our results. Our data identified that 57.3% of the P. aeruginosa isolates produced biofilm. P. aeruginosa produces several extracellular proteases such as elastase lasB that are important virulence factors which damage host tissues during host infection and interfere with host antibacterial defense mechanisms [35, 36] . Over 75% of the clinical isolates of P. aeruginosa secrete elastase lasB [37] . Yu H et al. studied the impact of lasB on biofilm formation of P. aeruginosa PAO1 and indicated that lasB could promote biofilm formation partly through the rhamnolipid-mediated regulation [38] . In a study, Tielen et al. showed that lasB can influence the formation and architecture of mucoid P. aeruginosa SG81 biofilm as a result of changes in the matrix composition and properties [12] . In this study, there was no statistically significant relationship between lasB and biofilm formation. In another study, Oldak et al. reported that the colony of biofilms formed by strains of P. aeruginosa secreted elastase lasB and the proteolytic activities of the colony biofilms studied were significantly reduced after exposure to ciprofloxacin at bactericidal concentrations relative to the control biofilms [36] . In a study performed by Deptula et al., lasA and lasB activities were observed in multidrug resistance P. aeruginosa clinical isolates [39] . Moreover, Sun et al. and Najafi et al. indicated that low lasB activity was observed in all the β-lactam-resistant isolates [40, 41] . In the present study, we observed a significant association between antibiogram results of isolates with and without the elastase gene. Based on our findings, the isolates without elastase were more sensitive to imipenem and piperacillin/tazobactam. Fricks-Lima et al. showed that a significant positive correlation between biofilm resistance and biofilm formation existed for imipenem in P. aeruginosa isolates suggesting that resistance to this antimicrobial strongly correlated with biofilm formation [42] . In another study, Delissalde et al. reported that biofilm producing isolates of P. aeruginosa were more resistant to piperacillin/tazobactam and imipenem than non-biofilm producing isolates [43] . The data indicates the possibility that there may be a link between biofilm formation and resistance to these antibiotics.
CONCLUSION
The present study shows a high prevalence of biofilmproducing P. aeruginosa isolates among burn patients in Taleghani Hospital in Ahvaz and that most of these isolates produce elastase lasB. Although a statistically significant relationship was not found among elastase gene (lasB) and biofilm formation in P. aeruginosa, strains isolated from burn patients, isolates without lasB show more sensitivity to imipenem and piperacillin/ tazobactam than isolates with lasB. Moreover, a high rate of resistance was observed against most antibiotics. This is a cause for concern because it poses a serious therapeutic challenge due to the limited treatment options. Based on results of this investigation, colistin and azithromycin still retain a high sensitivity. Therefore, they could be used as therapeutic alternatives in cases of P. aeruginosa burn infections.
